KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $405,985 | -26.9% | 2,401 | -6.3% | 0.00% | – |
Q2 2023 | $555,570 | -0.9% | 2,562 | -17.0% | 0.00% | – |
Q1 2023 | $560,723 | -7.7% | 3,087 | -0.1% | 0.00% | -100.0% |
Q4 2022 | $607,185 | -13.4% | 3,090 | -0.9% | 0.00% | 0.0% |
Q3 2022 | $701,000 | +75.7% | 3,117 | -1.0% | 0.00% | – |
Q2 2022 | $399,000 | -42.0% | 3,150 | -42.0% | 0.00% | -100.0% |
Q1 2022 | $688,000 | -4.7% | 5,428 | -1.5% | 0.00% | 0.0% |
Q4 2021 | $722,000 | +6.6% | 5,509 | -0.5% | 0.00% | 0.0% |
Q3 2021 | $677,000 | +3.8% | 5,538 | -3.2% | 0.00% | 0.0% |
Q2 2021 | $652,000 | -5.5% | 5,720 | -0.3% | 0.00% | 0.0% |
Q1 2021 | $690,000 | +18.2% | 5,738 | -0.1% | 0.00% | 0.0% |
Q4 2020 | $584,000 | +26.4% | 5,745 | -3.8% | 0.00% | 0.0% |
Q3 2020 | $462,000 | -30.7% | 5,974 | -0.2% | 0.00% | 0.0% |
Q2 2020 | $667,000 | +155.6% | 5,987 | +65.0% | 0.00% | – |
Q1 2020 | $261,000 | -51.3% | 3,629 | -49.0% | 0.00% | -100.0% |
Q4 2019 | $536,000 | – | 7,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |